ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
June 18, 2021Harrow Health, Inc. an ophthalmic-focused healthcare company, today announced the closing of its underwritten registered public offering of $20 million aggregate principal amount of 8.625% senior notes due 2026 (the "Notes") -
Surface Ophthalmics Announces First Patient Dosed in SURF-200 Trial for Acute Dry Eye
February 10, 2021Surface Ophthalmics announced the first patient has been dosed in the Phase II clinical trial for its investigational product SURF-200 (betamethasone in Klarity® vehicle) for the treatment of acute dry eye.
Pharma Sources Insight January 2025
